VEGF gene therapy (Fornix)

N/A

Report date: 2022/02/17 14:32:11

Base Information

Drug NameVEGF gene therapy (Fornix)
Drug Alias Namediabetic macroangiopathy gene therapy
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionVascular endothelial growth factor gene transference
TargetsVascular endothelial growth factor
Therapy Area/IndicationsDiabetic Angiopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFornix Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFornix Biosciences
Active IndicationsN/A
Inactive IndicationsDiabetic Angiopathies

Other Information

ATC CodeN/A
Related LinksN/A